Skip to content

Inhibrx Biosciences, Inc. INBX Balance Sheet Statement

FY'25FY'24FY'23
$124.22M-18.6%$152.6M-45.1%$277.92M+1.5%
$132.83M-17.2%$160.4M-45.7%$295.36M
$3.73M-39.8%$6.2M-3.4%$6.42M
$146.48M-19.0%$180.77M-41.3%$307.89M
$29.9M-22.7%$38.69M
$33.8M-17.0%$40.73M-27.7%$56.31M
$100.56M$0-100%$206.97M
$138.49M+194%$47.18M-82.2%$264.39M
120M+11,999,900%1K-80.0%5K
-$246.19M-132%-$106.13M+82.7%-$613.73M
$7.99M-94.0%$133.58M+207%$43.5M-25.1%
$146.48M-19.0%$180.77M-41.3%$307.89M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Inhibrx Biosciences, Inc.'s total assets?
Inhibrx Biosciences, Inc. (INBX) holds $184.0M in total assets, down 24.2% year over year.
How much debt does Inhibrx Biosciences, Inc. have?
Inhibrx Biosciences, Inc. carries $180.9M in total debt against -$21.0M of shareholders' equity, a debt-to-equity ratio of 13.39.
How much cash does Inhibrx Biosciences, Inc. have?
Inhibrx Biosciences, Inc. holds $161.7M in cash and equivalents.
Can Inhibrx Biosciences, Inc. cover its short-term obligations?
Its current ratio is 6.46 — current assets exceed current liabilities.
Where does Inhibrx Biosciences, Inc.'s balance sheet data come from?
Every line is extracted from Inhibrx Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.